Canagliflozin mitigates carfilzomib-induced endothelial apoptosis via an AMPK-dependent pathway
In conclusion, our findings demonstrate for the first time the direct toxic effects of CFZ in endothelial cells and the associated signaling changes. Canagliflozin abrogated the apoptotic effects of CFZ in endothelial cells in an AMPK-dependent mechanism, without interfering with its cytotoxicity in cancer cells.PMID:37247463 | DOI:10.1016/j.biopha.2023.114907
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Mohamed S Dabour Ibrahim Y Abdelgawad Marianne K O Grant Engie S El-Sawaf Beshay N Zordoky Source Type: research
More News: Canagliflozin | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Dapagliflozin | Drugs & Pharmacology | Empagliflozin | Forxiga | Grants | Heart | Invokana | Jardiance | Lymphoma | Myeloma | SGLT2 Inhibitors | Toxicology